Patent details

301233 Product Name: spesolimab

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
301233
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2780373
Status:
SPC granted but not yet in force
Application number:
301233
Procedural language:
Dutch
First Applicant Residence Country:
Germany (DE)

Paediatric Extension

SPC Extension Filing Date:
02/01/2025
SPC Extension Agent/Owner Name:
Boehringer Ingelheim International GmbH , ir. F.A. Geurts c.s.
SPC Extension Status:
Extension Granted
SPC Extension Grant Date:
27/02/2025
SPC Extension Request Refusal Date:
SPC Extension Revocation Date:

Marketing Authorization

Marketing Authorization Number:
EU/1/22/1688
Marketing Authorization Type:
EEA
Marketing Authorization Date:
12/12/2022
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
31/05/2023
First Marketing Authorization date:
12/12/2022
Grant date:
13/09/2023
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
31/05/2023
SPC/SPC Extension Expiration Date:
13/05/2038
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
31/05/2023
 
 

 

Name:
Boehringer Ingelheim International GmbH
Address:
Binger Strasse 173, 55216 INGELHEIM AM RHEIN, Germany (DE)

Agent

Name:
ir. F.A. Geurts c.s.
From:
31/05/2023
Address:
Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC
Journal edition number:
10/25
Publication date:
05/03/2025
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

2

Bulletin Heading:
SPC
Journal edition number:
02/25
Publication date:
08/01/2025
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

3

Bulletin Heading:
SPC
Journal edition number:
37/23
Publication date:
13/09/2023
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

4

Bulletin Heading:
SPC
Journal edition number:
23/23
Publication date:
07/06/2023
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Annual Fee

Annual Fee(s) Due Date:
30/11/2032
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
27/02/2025 Outgoing Correspondence Decision extension duration 1 PDF /2/9/0/0/8/0800880092/docs/301233_15_645917l504c.pdf
27/02/2025 Certificate Certificate 1 PDF /2/9/0/0/8/0800880092/docs/301233_16_spcxcertificate20250227112709492.pdf
03/01/2025 Outgoing Correspondence Confirmation receipt request for extension 2 PDF /2/9/0/0/8/0800880092/docs/301233_10_637681l505.pdf
02/01/2025 Application Form First filed application form 4 PDF /2/9/0/0/8/0800880092/docs/301233_9_applicationform20250103015127764.pdf
02/01/2025 SPC Documents Annex SPC 1 PDF /2/9/0/0/8/0800880092/docs/301233_11_supplprotectioncertificate20250102020729730.pdf
02/01/2025 SPC Documents Marketing Authorization SPC 3 PDF /2/9/0/0/8/0800880092/docs/301233_12_supplprotectioncertificate20250102020756138.pdf
02/01/2025 SPC Documents Summary of the characteristics of the product 29 PDF /2/9/0/0/8/0800880092/docs/301233_13_supplprotectioncertificate20250102020829220.pdf
02/01/2025 SPC Documents Annex SPC 1 PDF /2/9/0/0/8/0800880092/docs/301233_14_supplprotectioncertificate20250102020707738.pdf
13/09/2023 Outgoing Correspondence Decision grant 1 PDF /2/9/0/0/8/0800880092/docs/301233_0_566000l504a.pdf
13/09/2023 Certificate Certificate 1 PDF /2/9/0/0/8/0800880092/docs/301233_1_spcmedcertificate20230913084649983.pdf
31/05/2023 Application Form First filed application form 4 PDF /2/9/0/0/8/0800880092/docs/301233_2_applicationform20230531104543839.pdf
31/05/2023 SPC Documents Accompanying letter SPC 2 PDF /2/9/0/0/8/0800880092/docs/301233_3_supplprotectioncertificate20230531104611369.pdf
31/05/2023 SPC Documents Marketing Authorization SPC 3 PDF /2/9/0/0/8/0800880092/docs/301233_4_supplprotectioncertificate20230531104653097.pdf
31/05/2023 SPC Documents Annex SPC 4 PDF /2/9/0/0/8/0800880092/docs/301233_5_supplprotectioncertificate20230531104709757.pdf
31/05/2023 SPC Documents Annex SPC 1 PDF /2/9/0/0/8/0800880092/docs/301233_6_supplprotectioncertificate20230531104735271.pdf
31/05/2023 SPC Documents Summary of the characteristics of the product 13 PDF /2/9/0/0/8/0800880092/docs/301233_7_supplprotectioncertificate20230531104751366.pdf
31/05/2023 Outgoing Correspondence Confirmation receipt request 1 PDF /2/9/0/0/8/0800880092/docs/301233_8_547621l174.pdf